T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EA
351
DELISTED
Electronic Arts
EA
| $228M | 0.04% |
1,866,936
+257,679
| +16% | +$32.4M |
|
352
Elanco Animal Health
ELAN
$11.3B
| $228M | 0.04% |
18,651,639
-8,379,249
| -31% | -$104M |
|
353
Kohl's
KSS
$2.17B
| $228M | 0.04% |
9,013,096
+1,777,101
| +25% | +$50.4M |
|
|
SRCL
354
DELISTED
Stericycle Inc
SRCL
| $227M | 0.04% |
4,542,380
-1,843,724
| -29% | -$87.7M |
|
355
Essex Property Trust
ESS
$18.4B
| $226M | 0.04% |
1,068,336
+22,196
| +2% | +$4.85M |
|
356
TransDigm Group
TDG
$68.5B
| $226M | 0.04% |
358,970
+182,491
| +103% | +$108M |
|
357
Steel Dynamics
STLD
$37.8B
| $226M | 0.04% |
2,308,698
+309,009
| +15% | +$29.7M |
|
358
ICICI Bank
IBN
$106B
| $225M | 0.04% |
10,293,781
+587,488
| +6% | +$13.1M |
|
359
XP
XP
$8.07B
| $225M | 0.04% |
14,666,096
-5,686,183
| -28% | -$99.5M |
|
360
Darling Ingredients
DAR
$10.2B
| $224M | 0.04% |
3,582,267
-228,900
| -6% | -$16.1M |
|
361
Baidu
BIDU
$35.4B
| $223M | 0.04% |
1,950,615
-1,570,951
| -45% | -$160M |
|
362
Brown & Brown
BRO
$23.5B
| $216M | 0.03% |
3,792,975
-920,193
| -20% | -$53.8M |
|
363
Cameco
CCJ
$42.6B
| $216M | 0.03% |
9,512,121
-2,314,680
| -20% | -$54.4M |
|
364
Huazhu Hotels Group
HTHT
$12.5B
| $215M | 0.03% |
5,078,082
-7,785,324
| -61% | -$282M |
|
365
Expro Ltd
XPRO
$2.06B
| $215M | 0.03% |
11,864,259
-8,630
| -0.1% | -$146K |
|
366
VeriSign
VRSN
$25.5B
| $211M | 0.03% |
1,025,135
-6,673
| -0.6% | -$1.28M |
|
|
ETRN
367
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $210M | 0.03% |
31,316,116
-10,186,388
| -25% | -$79M |
|
368
Bruker
BRKR
$8.89B
| $209M | 0.03% |
3,064,401
-43,584
| -1% | -$2.77M |
|
369
Dentsply Sirona
XRAY
$2.27B
| $209M | 0.03% |
6,577,342
+23,998
| +0.4% | +$723K |
|
370
Canadian Natural Resources
CNQ
$97.5B
| $209M | 0.03% |
7,519,856
+1,234,722
| +20% | +$35.3M |
|
371
Trip.com Group
TCOM
$28.2B
| $208M | 0.03% |
6,053,319
-6,218,432
| -51% | -$179M |
|
|
SWAV
372
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $208M | 0.03% |
1,012,393
-784,628
| -44% | -$198M |
|
373
Gilead Sciences
GILD
$170B
| $207M | 0.03% |
2,410,038
+756,984
| +46% | +$59.9M |
|
|
SPR
374
DELISTED
Spirit AeroSystems
SPR
| $207M | 0.03% |
6,983,690
+341,325
| +5% | +$8.86M |
|
375
Colgate-Palmolive
CL
$73.8B
| $206M | 0.03% |
2,616,724
+30,834
| +1% | +$2.31M |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.